1-9 of 9
Maureen Okam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Over 4 Years of Safety and Efficacy with Voxelotor Treatment for Patients with Sickle Cell Disease: Updated Results from an Open-Label Extension of the Phase 3 HOPE Trial

Free
Maureen Okam Achebe, Hoda MA Hassab, Salam Al-Kindi, Clark Brown, Paul Telfer, Bart J. Biemond, Thokozeni Lipato, Mark Davis, Sarah Gray, Victor R. Gordeuk
Journal: Blood
Blood (2023) 142 (Supplement 1): 2527.
https://doi.org/10.1182/blood-2023-188616
Published: 2023
Journal Articles

Myeloid Neoplasia in Patients with Hereditary Hemoglobinopathies and Hemolytic Anemias (HHAs)

Free
Miriam A. Osei, Lauren E. Merz, Kelly S. Chien, Danielle E. Hammond, Coleman Lindsley, Marlise R. Luskin, Maximilian Stahl, Joan How, Mohammed Wazir, Anna E. Marneth, Shai Shimony, Ann Mullally, Daniel J. DeAngelo, Guillermo Garcia-Manero, Maureen Okam Achebe, Benjamin L. Ebert, Lachelle D. Weeks
Journal: Blood
Blood (2023) 142 (Supplement 1): 2427.
https://doi.org/10.1182/blood-2023-172992
Published: 2023
Journal Articles

Leg Ulcer Prevalence and Outcomes in a Real-World, Multicenter, Retrospective Study of Patients Treated with Voxelotor

Free
Caterina P Minniti, Henny H. Billett, Daniel McMahon, Modupe Idowu, Nirmish Shah, Richard A. Drachtman, Archana Sharma, Alexander Glaros, Maureen Okam Okam Achebe, Alecia C Nero, Susanna Curtis, Biree Andemariam
Journal: Blood
Blood (2022) 140 (Supplement 1): 8276–8277.
https://doi.org/10.1182/blood-2022-169334
Published: 2022
Journal Articles

Clinical Criteria for Transitioning from Oral to IV Iron Replacement Therapy in Patients with Iron Deficiency Anemia

Free
Maureen Okam, MD, Todd Koch, Minh Ha Tran, DO
Journal: Blood
Blood (2014) 124 (21): 211.
https://doi.org/10.1182/blood.V124.21.211.211
Published: 2014
Journal Articles

Regadenoson, An Adenosine 2A Receptor Agonist, Is Safe and Inhibits Invariant NKT Cells in Sickle Cell Disease

Free
Joshua Field, MD, MS, Gene Lin, MD, PhD, Maureen Okam, MD, MPH, Elaine Majerus, MD, PhD, Onyinye Onyekwere, MD, MS, Ainsley Ross, BA, Donna Neuberg, ScD, Federico Campigotto, MS, David G. Nathan, MD, Joel Linden, PhD
Journal: Blood
Blood (2011) 118 (21): 849.
https://doi.org/10.1182/blood.V118.21.849.849
Published: 2011
Journal Articles

Long-Term Follow-up of Adults with Severe Sickle Cell Disease After Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning

Free
Melinda A Biernacki, MD, Maureen Okam, MD, Shalini Shenoy, MD, Lakshmanan Krishnamurti, Associate, Professor, Pediatrics, Mitchell E. Horwitz, MD, Donna Neuberg, ScD, Joseph H. Antin, MD, Catherine J Wu, MD
Journal: Blood
Blood (2010) 116 (21): 261.
https://doi.org/10.1182/blood.V116.21.261.261
Published: 2010
Journal Articles

A Retrospective Comparison of Adverse Reaction Rates with the Use of Three Intravenous Iron Formulations: A Single Center Experience.

Free
Maureen Okam, MD, Elyse Mandell, ANP
Journal: Blood
Blood (2010) 116 (21): 1537.
https://doi.org/10.1182/blood.V116.21.1537.1537
Published: 2010
Journal Articles

National Hopitalization Rates for Sickle Cell Disease in the Hydroxyurea Era

Free
Maureen Okam, MD, Stuart Lipsitz, D., Sc.
Journal: Blood
Blood (2008) 112 (11): 1276.
https://doi.org/10.1182/blood.V112.11.1276.1276
Published: 2008
Journal Articles

Regulators of Erythrocyte Volume as Modifiers in Sickle Cell Disease: The Gardos Channel.

Free
Charles Tian, Maureen Okam, MD, Seth L. Alper, MD PhD, Martin H. Steinberg, MD, Carlo Brugnara, MD, Patrick G. Gallagher, MD
Journal: Blood
Blood (2007) 110 (11): 3387.
https://doi.org/10.1182/blood.V110.11.3387.3387
Published: 2007